Clinical Validation of Birch Pollen in the EEU

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Allergic Rhinitis
Interventions
OTHER

Birch Pollen

Participants will be exposed to birch pollen to activate their allergy symptoms therefore validating the unit.

PROCEDURE

Nasal Brushing

To assess allergic biomarkers participants will provide a nasal sample which will be collected using a cytobrush. This procedure will be performed twice; once at screening and once following pollen exposure in the EEU.

Trial Locations (1)

K7L 2V7

Kingston General Hospital, Kingston

All Listed Sponsors
collaborator

University of British Columbia

OTHER

lead

Queen's University

OTHER

NCT02351830 - Clinical Validation of Birch Pollen in the EEU | Biotech Hunter | Biotech Hunter